NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 171 filers reported holding NXSTAGE MEDICAL INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,701,000 | +2.7% | 94,348 | 0.0% | 0.04% | +40.0% |
| Q3 2018 | $2,631,000 | -0.1% | 94,348 | -0.0% | 0.02% | -3.8% |
| Q2 2018 | $2,633,000 | +12.2% | 94,362 | 0.0% | 0.03% | +8.3% |
| Q1 2018 | $2,346,000 | -3.7% | 94,362 | -6.1% | 0.02% | +4.3% |
| Q4 2017 | $2,435,000 | -12.9% | 100,483 | -0.8% | 0.02% | 0.0% |
| Q3 2017 | $2,795,000 | +6.4% | 101,273 | -3.3% | 0.02% | +4.5% |
| Q2 2017 | $2,626,000 | -7.2% | 104,743 | -0.7% | 0.02% | -8.3% |
| Q1 2017 | $2,831,000 | +3.9% | 105,512 | +1.5% | 0.02% | +9.1% |
| Q4 2016 | $2,724,000 | -20.8% | 103,912 | -24.5% | 0.02% | -18.5% |
| Q3 2016 | $3,439,000 | +15.2% | 137,622 | 0.0% | 0.03% | +8.0% |
| Q2 2016 | $2,984,000 | +44.6% | 137,622 | +0.0% | 0.02% | +25.0% |
| Q1 2016 | $2,063,000 | -19.4% | 137,608 | +17.8% | 0.02% | -20.0% |
| Q4 2015 | $2,559,000 | – | 116,812 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |